Bot Chart, page-11633

I have no plans on selling any shares at all at this stage.

There is no other bio with an established revenue stream in overseas markets already that is about to be FDA approved and still has game changing acne and antibiotic platforms in the pipeline.

The market is still severely punishing Botanix for the phase 2 acne trial in my opinion.

The other programmes are why i am here originally. I would love to see these move forward.

The market cap here is an insult to every investor in the asx. From here i see the share price swiftly moving past 20 cents closer to 30 cents into approval.

Beyond that we should comfortably sit over a billion dollars market cap.

I still cannot see anything else that comes close to this company to invest in on the asx.

All my humble opinion of course!